Breast cancer is highly prevalent among women and it is caused due to uncontrolled cell growth, which generally leads to the formation of a tumor that is felt as a lump. As per the statistics released by the National Cancer Institute (NCI), in the U.S., over 3 million women were diagnosed with breast cancer in 2014. Furthermore, the incidence of breast cancer was the highest in Belgium in 2012, as per the observations of the World Cancer Research Fund International (WCRF). 

Furthermore, both under-developed and developing countries reported several cases of breast cancer, accounting for around 53% of the cases across the world. The growing incidence of this disease is one of the major growth drivers of the breast biopsy devices market. Besides, the rapid technological advancements being made in breast imaging devices such as the development of ultrasound- and mammography-guided biopsy, core-needle biopsy, excisional breast biopsy, and fine-needle aspiration biopsy are also fueling the growth of the market. 

Based on product, the market is divided into guidance systems, biopsy needles/guns, biopsy wires, and biopsy tables category. Out of these, the biopsy needles or guns category is predicted to exhibit the fastest growth in the market in the forthcoming years. In addition to this, this category is also expected to hold the largest share in the market in the upcoming years. When procedure type is taken into consideration, the breast biopsy devices market is categorized into vacuum-assisted, core-needle, surgical, and fine-needle aspiration.

Out of these, the vacuum-assisted biopsy category dominated the market in 2017, owing to the large-scale adoption of this procedure, on account of its ability to accurately locate the abnormality area, so that only a few samples from the infected region are taken. This category is also expected to demonstrate the fastest growth in the market in the years to come. Geographically, Europe and North America led the breast biopsy devices market in 2017.

The U.S. recorded huge sales of breast biopsy devices during the last few years, primarily because of the surging geriatric population, rising incidence of breast cancer, rapid economic growth, booming private healthcare sector, and high healthcare expenditure of the country. In addition to this, many biotechnology and pharmaceutical companies, federal agencies, public health associations, research institutes, local and state governments, and professional societies are making huge investments in country’s health-related research and development (R&D) and medical programs. 

Hence, it is clear that the market will grow massively in the upcoming years, primarily because of the growing incidence of breast cancer and the surging population of geriatric women all over the world.